BiotechTube
Home/Neurizon Therapeutics/Sergio Duchini
SD

Sergio Duchini

Executive Chairman

Neurizon Therapeutics

Therapeutic Areas

Amyotrophic Lateral Sclerosis (ALS)Alzheimer's DiseaseParkinson's DiseaseHuntington's Disease

Neurizon Therapeutics Pipeline

DrugIndicationPhase
NUZ-001Amyotrophic Lateral Sclerosis (ALS)Phase 2/3 (Platform Trial)

Leadership Team at Neurizon Therapeutics

DK
Dr Katie MacFarlane
Non‑Executive Director
View full Neurizon Therapeutics profile